Skip to main content
Clinical Trials/NCT02078401
NCT02078401
Unknown
N/A

Ophthalmological Screening and Follow-up of Optic Pathway Gliomas in Children With Neurofibromatosis Type 1.

Universitaire Ziekenhuizen KU Leuven1 site in 1 country200 target enrollmentApril 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neurofibromatosis Type 1
Sponsor
Universitaire Ziekenhuizen KU Leuven
Enrollment
200
Locations
1
Primary Endpoint
Visual acuity
Last Updated
11 years ago

Overview

Brief Summary

The goal of this project is to get more insight into the (neuro)ophthalmological characteristics of children with neurofibromatosis type 1. This way investigators would like to update the current guidelines for follow up and treatment of optic pathway gliomas. Clinical findings will be compared with the results of Optical coherence tomography (OCT) and MRI (magnetic resonance imaging).

Registry
clinicaltrials.gov
Start Date
April 2014
End Date
August 2014
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Catherine Cassiman

MD

Universitaire Ziekenhuizen KU Leuven

Eligibility Criteria

Inclusion Criteria

  • neurofibromatosis type 1

Exclusion Criteria

  • no neurofibromatosis type 1

Outcomes

Primary Outcomes

Visual acuity

Time Frame: childhood (0 to 18y)

Presence of optic pathway glioma

Time Frame: childhood (0 to18y)

Study Sites (1)

Loading locations...

Similar Trials